Front Row Advisors LLC - HUTCHISON CHINA MEDITECH LTD ownership

HUTCHISON CHINA MEDITECH LTD's ticker is HCM and the CUSIP is 44842L103. A total of 145 filers reported holding HUTCHISON CHINA MEDITECH LTD in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
Front Row Advisors LLC ownership history of HUTCHISON CHINA MEDITECH LTD
ValueSharesWeighting
Q2 2022$1,000
-50.0%
50
-47.4%
0.00%
-100.0%
Q1 2022$2,000
-33.3%
95
+5.6%
0.00%0.0%
Q4 2021$3,0000.0%900.0%0.00%0.0%
Q3 2021$3,000
-25.0%
90
-3.2%
0.00%
-50.0%
Q2 2021$4,000
+100.0%
93
+5.7%
0.00%
+100.0%
Q1 2021$2,000
-33.3%
88
+2.3%
0.00%
-50.0%
Q4 2020$3,0000.0%860.0%0.00%0.0%
Q3 2020$3,000860.00%
Other shareholders
HUTCHISON CHINA MEDITECH LTD shareholders Q4 2021
NameSharesValueWeighting ↓
Zeal Asset Management Ltd 2,684,118$84,523,00016.48%
Cederberg Capital Ltd 3,400,000$108,868,0002.00%
Capital International Sarl 570,500$18,267,0001.91%
AIA Group Ltd 437,118$14,971,0001.72%
Capital International, Inc./CA/ 4,711,405$150,859,0001.40%
M&G INVESTMENT MANAGEMENT LTD 3,096,345$99,083,0000.62%
Bellevue Group AG 947,674$30,345,0000.35%
Sands Capital Management 7,051,916$225,802,0000.22%
E Fund Management (Hong Kong) Co., Ltd. 18,836$603,0000.21%
Hudson Bay Capital Management LP 1,031,212$33,020,0000.18%
View complete list of HUTCHISON CHINA MEDITECH LTD shareholders